🇺🇸 FDA
Pipeline program

Zaroxolyn 5 mg compresse, Zaroxolyn 10 mg compresse, DIAMOX 250 mg compresse

CCM 1862

Phase 3 small_molecule active

Quick answer

Zaroxolyn 5 mg compresse, Zaroxolyn 10 mg compresse, DIAMOX 250 mg compresse for congestive heart failure is a Phase 3 program (small_molecule) at Cardiol Therapeutics with 1 ClinicalTrials.gov record(s).

Program details

Company
Cardiol Therapeutics
Indication
congestive heart failure
Phase
Phase 3
Modality
small_molecule
Status
active

Clinical trials